期刊文献+

曲美他嗪联合阿托伐他汀治疗冠心病心绞痛的临床疗效观察 被引量:70

Effect of trimetazidine combined with atorvastatin treatment of angina pectoris
下载PDF
导出
摘要 目的 研究曲美他嗪联合阿托伐他汀治疗冠心病心绞痛的临床疗效.方法选择2010 年1 月~2013 年1 月在我院住院治疗的冠心病心绞痛患者72 例,全部患者随机分为观察组和对照组各36 例.两组均给予β-受体阻滞剂、硝酸酯类、钙拮抗剂等常规对症治疗及曲美他嗪每次20 mg,每日3 次.观察组同时给予阿托伐他汀每次20 mg,每日1 次,疗程2 周.结果 两组心绞痛症状的疗效比较:观察组的显效率61.1%、总有效率达94.4%,分别高于对照组47.2%、77.8%,组间比较,差异具有显著性(P<0.05).两组心电图改善情况的疗效比较:观察组的显效率50.0%、总有效率达88.9%,分别高于对照组33.3%、72.2%,组间比较,差异具有显著性(P<0.05).结论曲美他嗪联合阿托伐他汀治疗冠心病心绞痛疗效确切,安全性好,值得推广和应用. Objective To study the effect of trimetazidine combined with atorvastatin in treatment of angina pectoris. Methods From January 2010 to January 2013 in our hospital, 72 patients with angina pectoris were randomly divided into observation group and control group,each of 36 cases. Both groups were treated with β-blockers, nitrates, calcium antagonists and other conventional symptomatic treatment, and every time trimetazidine 20 mg, 3 times a day. Observation group added atorvastatin per 20 mg, once a day for 2 weeks. Results The two groups compared the efficacy of angina symptoms: the efficiency of the observation group was 61.1%, the total effective rate was 94.4%, respectively, was higher than the control group, the difference was significant between two groups (P〈0.05). The efficacy of ECG im- prove the situation: efficiency rate of the observation group were 50.0%, the total effective rate was 88.9%, respectively, was higher than the control group, the difference was significant between two groups(P〈0.05). Conclusion Trimetazidine combined with atorvastatin in treatment of angina peetoris has efficacy and safety, and it is worthy of promotion and application.
作者 穆瑞斌
出处 《中国现代医生》 2014年第3期51-53,共3页 China Modern Doctor
关键词 冠心病心绞痛 曲美他嗪 联合 阿托伐他汀 Angina pectoris Trimetazidine Joint Atorvastatin
  • 相关文献

参考文献13

二级参考文献47

  • 1李华,杨守忠.阿托伐他汀对不稳定型心绞痛患者C-反应蛋白的影响及临床意义[J].海南医学,2007,18(4):122-123. 被引量:12
  • 2骆丽菊,傅国胜.曲美他嗪治疗老年稳定型心绞痛疗效观察[J].浙江预防医学,2007,19(4):87-87. 被引量:9
  • 3张照.丹参注射液对心脏微循环的影响[J].病理生理学报,1985,1(2):19-22.
  • 4金惠铭.丹参制剂的临床应用及其活血化瘀原理的研究[J].中华医学杂志,1978,58(3):180-182.
  • 5Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase[J].Circ Res,2000,86(5):580-588.
  • 6Allibardi S,Chierchia SL,Margonato V,et al.Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts[J].Cardiovasc Drugs Ther,1998,12(6):543-549.
  • 7Belardinelli R,Purcaro A.Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy[J].Eur Heart J,2001,22(23):2164-2710.
  • 8Lu C,Dabrowski P,Fragasso G,et al.Effects of trimetazidine on ischemic leftventricular dysfunction in patients with coronary artery disease[J].Am J Cardiol,1998,82(7):898-901.
  • 9李焕德,卢安瑛,刘世坤.临床实用新药[M].3版.北京:人民卫生出版社,2006:271.
  • 10Mohand-snid S,Jacquet A.Protective effect of trimetazidine in a model of ischemia-reperfusion in the rat retina[J].Ophthalmic Res,2002,34(5):300-305.

共引文献83

同被引文献398

二级引证文献407

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部